Rybelsus 14 mg Tablets

Rybelsus 14 mg Tablets

Rybelsus 14 mg is an oral GLP-1 receptor agonist used for the management of Type 2 diabetes mellitus. It contains semaglutide, a clinically proven medicine that helps improve blood sugar control when used along with a healthy diet and regular exercise. Unlike injectable GLP-1 therapies, Rybelsus offers the convenience of a once-daily tablet.

Product Details

• Brand: RYBELSUS

• Manufacturer: Novo Nordisk

• Strength: 14 mg

• Form: Tablets

• Packaging Size: 10 × 10 Tablets

• Packaging Type: Strip

Price Information

• MRP: ₹3,628 /-

• Our Price: ₹2,900 / Stripe

• Minimum Order Quantity: 2 Stripes

Key Benefits

• Helps lower fasting and post-meal blood glucose levels

• Stimulates insulin release in a glucose-dependent manner

• Reduces excess glucose production by the liver

• Supports weight reduction in many patients

• Convenient oral alternative to injectable GLP-1 medications

Uses

Rybelsus 14 mg is prescribed for:

• Management of Type 2 diabetes mellitus

• Improving glycemic control in adults when diet and exercise alone are insufficient

How It Works

Semaglutide, the active ingredient, is a GLP-1 receptor agonist that:

• Enhances insulin secretion after meals

• Suppresses glucagon release

• Slows gastric emptying, helping control appetite and blood sugar spikes

Dosage & Administration

• Taken once daily, preferably in the morning

• Swallow with a small amount of water (no more than 120 ml)

• Wait at least 30 minutes before eating, drinking, or taking other medicines

• Dosage should be strictly as prescribed by a healthcare professional

Possible Side Effects

• Nausea, vomiting, diarrhea

• Decreased appetite

• Abdominal discomfort

• Rarely, hypoglycemia (especially when used with other diabetes medicines)

Storage Instructions

• Store at room temperature below 30°C

• Keep away from moisture and direct sunlight

Important Note:

Rybelsus is a prescription-only medication and should be used under medical supervision. Regular blood glucose monitoring is recommended for best results.

Rybelsus 14 mg offers an effective, needle-free solution for long-term Type 2 diabetes management with proven clinical benefits.